These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20681478)

  • 21. Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist.
    Kramer JA; Curran D; Piccart M; de Haes JC; Bruning PF; Klijn JG; Bontenbal M; van Pottelsberghe C; Groenvold M; Paridaens R
    Eur J Cancer; 2000 Aug; 36(12):1488-97. PubMed ID: 10930796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.
    Chan S; Friedrichs K; Noel D; Pintér T; Van Belle S; Vorobiof D; Duarte R; Gil Gil M; Bodrogi I; Murray E; Yelle L; von Minckwitz G; Korec S; Simmonds P; Buzzi F; González Mancha R; Richardson G; Walpole E; Ronzoni M; Murawsky M; Alakl M; Riva A; Crown J;
    J Clin Oncol; 1999 Aug; 17(8):2341-54. PubMed ID: 10561296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
    Spigel DR; Hainsworth JD; Burris HA; Molthrop DC; Peacock N; Kommor M; Vazquez ER; Greco FA; Yardley DA
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):280-6. PubMed ID: 21558987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin.
    Trail PA; Willner D; Bianchi AB; Henderson AJ; TrailSmith MD; Girit E; Lasch S; Hellström I; Hellström KE
    Clin Cancer Res; 1999 Nov; 5(11):3632-8. PubMed ID: 10589780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel: new preparation. No first-line use in metastatic breast cancer.
    Prescrire Int; 2001 Dec; 10(56):178-9. PubMed ID: 11824441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of radiation-induced angiosarcoma of the breast in an elderly patient.
    Hoffmann G; Mylonas I
    Arch Gynecol Obstet; 2013 Apr; 287(4):827-31. PubMed ID: 23008109
    [No Abstract]   [Full Text] [Related]  

  • 28. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
    Chen HR; Sherr DH; Hu Z; DeLisi C
    BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Literature mining, ontologies and information visualization for drug repurposing.
    Andronis C; Sharma A; Virvilis V; Deftereos S; Persidis A
    Brief Bioinform; 2011 Jul; 12(4):357-68. PubMed ID: 21712342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials in cancer medicine.
    Snyder RD; Schwarz MA
    Aust Fam Physician; 1980 Jan; 9(1):23-6. PubMed ID: 6154456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adjuvant chemotherapy for breast cancer and targeted therapies].
    Dufresne A; Bachelot T; Blay JY
    Rev Prat; 2008 Mar; 58(5):477-8. PubMed ID: 18524101
    [No Abstract]   [Full Text] [Related]  

  • 32. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy.
    Kirk J; Shah N; Noll B; Stevens CB; Lawler M; Mougeot FB; Mougeot JC
    Support Care Cancer; 2018 Aug; 26(8):2695-2705. PubMed ID: 29476419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over.
    Paridaens R; Biganzoli L; Bruning P; Klijn JG; Gamucci T; Houston S; Coleman R; Schachter J; Van Vreckem A; Sylvester R; Awada A; Wildiers J; Piccart M
    J Clin Oncol; 2000 Feb; 18(4):724-33. PubMed ID: 10673513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant nab-paclitaxel in the treatment of breast cancer.
    Ueno NT; Mamounas EP
    Breast Cancer Res Treat; 2016 Apr; 156(3):427-440. PubMed ID: 27072366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PheWAS-Based Systems Genetics Methods for Anti-Breast Cancer Drug Discovery.
    Gao M; Quan Y; Zhou XH; Zhang HY
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30781719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
    Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
    Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure.
    Guo B; Villeneuve DJ; Hembruff SL; Kirwan AF; Blais DE; Bonin M; Parissenti AM
    Breast Cancer Res Treat; 2004 May; 85(1):31-51. PubMed ID: 15039596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage chemotherapy of breast cancer.
    Norton L
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):19-24. PubMed ID: 8091238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of biological processes and diseases using text mining approaches.
    Krallinger M; Leitner F; Valencia A
    Methods Mol Biol; 2010; 593():341-82. PubMed ID: 19957157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.